Literature DB >> 21740274

HIV type 1 subtype surveillance in central Kenya.

Sheila Kageha1, Raphael W Lihana, Vincent Okoth, Matilu Mwau, Fredrick A Okoth, Elijah M Songok, Jane M Ngaira, Samoel A Khamadi.   

Abstract

Human immunodeficiency virus 1 (HIV-1) infection is characterized by genetic diversity such that specific viral subtypes are predominant in specific geographic areas. To determine circulating subtypes of HIV-1 in different parts of central Kenya, a cross-sectional study was carried out on HIV-1-positive blood samples collected from consenting individuals in eight hospitals of Kenya's central province. Proviral DNA was extracted from peripheral blood mononuclear cells. Polymerase chain reaction and direct sequencing using primers generated from a highly conserved region of HIV-1 env gp41 were carried out. Ninety-six samples were successfully amplified and sequenced. Analysis of the sequences showed that a majority of them belonged to subtype A1 (67/96, 69.8%), followed by subtypes D (18, 18.7%) and C (11/96, 11.5%). Consistent with findings in other parts of Kenya, HIV-1 subtype A1 was the most dominant virus in circulation. Continued surveillance of circulating subtypes of HIV-1 in Kenya is important in determining the evolution of the HIV/AIDS epidemic in Kenya.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21740274     DOI: 10.1089/aid.2011.0089

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  10 in total

1.  HIV-1-specific enzyme-linked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls.

Authors:  Brandon L Guthrie; Barbara Lohman-Payne; Amy Y Liu; Rose Bosire; Samuel Victor Nuvor; Robert Y Choi; Romel D Mackelprang; James N Kiarie; Stephen C De Rosa; Barbra A Richardson; Grace C John-Stewart; Carey Farquhar
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

2.  HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.

Authors:  Rami Kantor; Allison DeLong; Maya Balamane; Leeann Schreier; Robert M Lloyd; Wilfred Injera; Lydia Kamle; Fidelis Mambo; Sarah Muyonga; David Katzenstein; Joseph Hogan; Nathan Buziba; Lameck Diero
Journal:  J Int AIDS Soc       Date:  2014-11-18       Impact factor: 5.396

3.  Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART.

Authors:  Rose C Kitawi; Carol W Hunja; Rashid Aman; Bernhards R Ogutu; Anne W T Muigai; Gilbert O Kokwaro; Washingtone Ochieng
Journal:  Virol J       Date:  2017-02-14       Impact factor: 4.099

4.  Conserved HIV Epitopes for an Effective HIV Vaccine.

Authors:  Bikash Sahay; Cuong Q Nguyen; Janet K Yamamoto
Journal:  J Clin Cell Immunol       Date:  2017-08-30

5.  HIV-1 subtype diversity, transmission networks and transmitted drug resistance amongst acute and early infected MSM populations from Coastal Kenya.

Authors:  Amin S Hassan; Joakim Esbjörnsson; Elizabeth Wahome; Alexander Thiong'o; George N Makau; Mathew A Price; Eduard J Sanders
Journal:  PLoS One       Date:  2018-12-18       Impact factor: 3.240

6.  Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999-2018.

Authors:  Nalia Ismael; Eduan Wilkinson; Isabel Mahumane; Hernane Gemusse; Jennifer Giandhari; Adilson Bauhofer; Adolfo Vubil; Pirolita Mambo; Lavanya Singh; Nédio Mabunda; Dulce Bila; Susan Engelbrecht; Eduardo Gudo; Richard Lessells; Túlio de Oliveira
Journal:  Viruses       Date:  2022-09-09       Impact factor: 5.818

7.  Phylodynamics of HIV-1 subtype C epidemic in east Africa.

Authors:  Edson Oliveira Delatorre; Gonzalo Bello
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

8.  The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.

Authors:  Erik Billings; Eric Sanders-Buell; Meera Bose; Andrea Bradfield; Esther Lei; Gustavo H Kijak; Miguel A Arroyo; Rukia M Kibaya; Paul T Scott; Monique K Wasunna; Frederick K Sawe; Douglas N Shaffer; Deborah L Birx; Francine E McCutchan; Nelson L Michael; Merlin L Robb; Jerome H Kim; Sodsai Tovanabutra
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

9.  Deciphering the complex distribution of human immunodeficiency virus type 1 subtypes among different cohorts in Northern Tanzania.

Authors:  Harr F Njai; Fiona M Ewings; Eric Lyimo; Vincent Foulongne; Dhamira Ngerageza; Aika Mongi; Deogratius Ssemwanga; Aura Andreasen; Balthazar Nyombi; Tony Ao; Denna Michael; Mark Urassa; Jim Todd; Basia Zaba; John Changalucha; Richard Hayes; Saidi H Kapiga
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

10.  Human immunodeficiency virus (HIV) type 1 genetic diversity in HIV positive individuals on antiretroviral therapy in a cross-sectional study conducted in Teso, Western Kenya.

Authors:  Maureen Adhiambo; Olipher Makwaga; Ferdinard Adungo; Humphrey Kimani; David Hughes Mulama; Jackson Cheruiyot Korir; Matilu Mwau
Journal:  Pan Afr Med J       Date:  2021-04-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.